[Federal Register Volume 76, Number 197 (Wednesday, October 12, 2011)]
[Notices]
[Pages 63341-63342]
[FR Doc No: 2011-26267]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Environmental Impact Statement: Igor Sikorsky Memorial Airport,
Stratford, Connecticut

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of Availability.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public that a
Record of Decision (ROD), resulting from an Environmental Impact
Statement (EIS) Re-evaluation has been prepared for Sikorsky Memorial
Airport in Stratford, Connecticut.

FOR FURTHER INFORMATION CONTACT: Richard Doucette, Environmental

Program Manager, Federal Aviation Administration New England, 12 New
England Executive Park, Burlington, MA 01803. Telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The FAA is making available a ROD regarding
Runway Safety Areas at Sikorsky Memorial Airport in Stratford,
Connecticut. The ROD documents the final Agency decisions regarding the
proposed projects as described and analyzed in the EIS Re-evaluation.
The ROD is available for review during normal business hours at the
following locations: FAA New England Region, Airports Division, 16 New
England Executive Park, Burlington, MA. Telephone<PHONE_NUMBER> and at
Sikorsky Memorial Airport, 1000 Great Meadow Road Terminal Building,
Stratford, Connecticut 06497.

    Issued on: September 28, 2011.
Bryon H. Rakoff,
Acting Manager, Airports Division.
[FR Doc. 2011-26267 Filed 10-11-11; 8:45 am]
BILLING CODE 4910-13-P


 [Federal Register Volume 76, Number 130 (Thursday, July 7, 2011)] [Notices] [Pages 39960-39963] [FR Doc No: 2011-16963]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-64780; File No. SR-NYSEArca-2011-40]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing

and Immediate Effectiveness of Proposed Rule Change Amending Certain

Rules and Adding New Rules so That They Remain Substantially Similar to

Corresponding Financial Industry Regulatory Authority Rules in

Accordance With a Rule 17d-2 Agreement

 June 30, 2011.

    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of

1934 (``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby given

that, on June 20, 2011, NYSE Arca, Inc. (the ``Exchange'' or ``NYSE

Arca'') filed with the Securities and Exchange Commission

(``Commission'') the proposed rule change as described in Items I and

II below, which Items have been prepared by the self-regulatory

organization. The Commission is publishing this notice to solicit

comments on the proposed rule change from interested persons.

---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).

    \2\ 15 U.S.C. 78a.

    \3\ 17 CFR 240.19b-4.

---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance

of the Proposed Rule Change

    The Exchange proposes to amend certain rules and add new rules so

that they remain substantially similar to corresponding Financial

Industry Regulatory Authority (``FINRA'') rules in accordance with a

Rule 17d-2 agreement between the two self-regulatory organizations. The

text of the proposed rule change is available at the Exchange, the

Commission's Public Reference Room, and http://www.nyse.com.

II. Self-Regulatory Organization's Statement of the Purpose of, and

Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization

included statements concerning the purpose of,

and basis for, the proposed rule change and discussed any comments it

received on the proposed rule change. The text of those statements may

be examined at the places specified in Item IV below. The Exchange has

prepared summaries, set forth in sections A, B, and C below, of the

most significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and

Statutory Basis for, the Proposed Rule Change

1. Purpose

    The Exchange proposes to amend certain rules and add new rules so

that they remain substantially similar to corresponding FINRA \4\ rules

for purposes of a Rule 17d-2 agreement between the two SROs.\5\

---------------------------------------------------------------------------

    \4\ FINRA was formerly known as the National Association of

Securities Dealers, Inc. or ``NASD'' and is the successor entity

with respect to the Rule 17d-2 agreement discussed herein.

    \5\ See Securities Exchange Act Release No. 55505 (March 22,

2007), 72 FR 14628 (March 28, 2007).

---------------------------------------------------------------------------

Background

    SEC Rule 17d-2 \6\ permits SROs to propose joint plans for the

allocation of regulatory responsibilities, other than financial

responsibility rules, with respect to their common members. Under

paragraph (c) of Rule 17d-2, the Commission may declare such a plan

effective if, after providing for appropriate notice and comment, it

determines that the plan is necessary or appropriate in the public

interest and for the protection of investors, to foster cooperation and

coordination among the SROs, to remove impediments to, and foster the

development of, a national market system and a national clearance and

settlement system, and is in conformity with the factors set forth in

Section 17(d) of the Securities Exchange Act of 1934, as amended (the

``Act''). Upon effectiveness of a plan filed pursuant to Rule 17d-2, an

SRO is relieved of those regulatory responsibilities for common members

that are allocated by the plan to another SRO.

---------------------------------------------------------------------------

    \6\ See 17 CFR 240.17d-2.

---------------------------------------------------------------------------

    The Commission has issued an order granting approval and declaring

effective a plan filed by NYSE Arca and NASD (together the ``Parties'')

dated February 9, 2007 (``the Plan'') under which regulatory

responsibility for Common Rules is allocated to NASD.\7\ ``Common

Rules'' are defined as NYSE Arca Equities rules that are substantially

similar to NASD rules in that NYSE Arca's rule would not require NASD

to develop one or more new examination standards, modules, procedures,

or criteria in order to analyze the application of the rule, or a dual

member's activity, conduct or output in relation to such rule. The Plan

includes an attachment, ``NYSE Arca Rules Certification for 17d-2

Agreement with NASD,'' that lists Common Rules.

---------------------------------------------------------------------------

    \7\ See Securities Exchange Act Release No. 55505 (March 22,

2007), 72 FR 14628 (March 28, 2007). The Parties first entered into

a Rule 17d-2 agreement in 1977, which thereafter was amended several

times. See Securities Exchange Act Release No. 54394 (August 31,

2006), 71 FR 52827 n. 14 (September 7, 2006) (``2006 Release'').

---------------------------------------------------------------------------

Proposed Rule Change

    In accordance with Paragraph 2 of the Plan, the Exchange has

undertaken a review of the Common Rules. In order to maintain the

current list of Common Rules under the Plan, the Exchange proposes to

amend certain its rules or add new NYSE Arca Equities rules so that

they remain substantially similar to corresponding FINRA rules as

described below.\8\

---------------------------------------------------------------------------

    \8\ Because the Parties will only be adding to, deleting from,

or confirming changes to NYSE Arca rules in the Certification in

conformance with the definition of Common Rules, the modifications

to the Certification need not be filed with the Commission as an

amendment to the Plan. See 2006 Release at 52829. If the Commission

approves [sic] the proposed rule change, NYSE Arca will submit the

updated list of Common Rules to FINRA for its confirmation in

accordance with the Plan.

---------------------------------------------------------------------------

    NYSE Arca Equities Rule 2.21(a) and (i) would be amended to delete

references to filing paper registration forms for registration

categories not available electronically on CRD because such categories

no longer exist and thus all NYSE Arca Equities registration forms are

filed electronically, as is the case with FINRA registrations pursuant

to FINRA Rule 1010(c). NYSE Arca Equities Rule 2.21(i) also would be

amended to change the period for filing Form U5 from 10 to 30 days to

conform it with FINRA's Form U5 filing period in Article VI, Section

3(a) of FINRA's Bylaws.

    NYSE Arca Equities Rule 2.21(d)(1)(B) would be amended to delete

references to any discretion for NYSE Arca with respect to compliance

with continuing education requirements to be consistent with NASD Rule

1120.

    NYSE Arca Equities Rule 2.21(e), which concerns outside business

activities, would be deleted and the text of FINRA Rule 3270 would be

adopted as new NYSE Arca Equities Rule 3270.\9\

---------------------------------------------------------------------------

    \9\ NYSE Arca Equities rule numbers that would no longer be used

would be marked ``Reserved.''

---------------------------------------------------------------------------

    NYSE Arca Equities Rules 2.21(g) and (h), which concerns gifts and

gratuities, would be deleted and the text of FINRA Rule 3220 would be

adopted as new NYSE Arca Equities Rule 3220.

    NYSE Arca Equities Rule 2.21(j) would be amended to remove the

requirement for approval of officers, for which FINRA does not have a

corresponding requirement, and to remove an outdated reference to a

change in continuing education requirements.

    NYSE Arca Equities Rule 6.6, which addresses frontrunning block

transactions, would be amended to change the number of shares that

would trigger application of the Rule from 5,000 to 10,000 shares to

make it consistent with FINRA's requirements under NASD IM-2110-3.

    NYSE Arca Equities Rule 6.16, which addresses trading ahead of

customer orders, would be deleted and the text of NASD IM-2110-2 would

be inserted in that Rule. The Exchange would also add new NYSE Arca

Equities Rule 6.16A, which would insert the text of NASD Rule 2111,

which concerns trading ahead of customer market orders.\10\

---------------------------------------------------------------------------

    \10\ The SEC has approved FINRA Rule 5320, which harmonizes NASD

IM-2110-2 and NASD Rule 2111 with New York Stock Exchange LLC

(``NYSE'') Rule 92. See Securities Exchange Act Release No. 63895

(February 11, 2011), 76 FR 9386 (February 17, 2011) (SR-FINRA-2009-

090). The anticipated implementation date of FINRA Rule 5320 is

September 12, 2011. See FINRA Regulatory Notice 11-24 (May 12,

2011). The Exchange, along with its affiliates, NYSE and NYSE Amex

LLC, will be submitting a rule filing to adopt the text of FINRA

Rule 5320 as part of its rules and implement the change concurrently

with FINRA. The proposed amendment to NYSE Arca Equities Rule 6.16

and the addition of Rule 6.16A will serve to harmonize NYSE Arca

Equities' requirements with FINRA's requirements in the interim

period until the September 12, 2011 implementation.

---------------------------------------------------------------------------

    NYSE Arca Equities Rule 9.1(a), which concerns an ETP Holder's

registration, would be amended to conform it with Article IV, Section

1(c) of FINRA's By-Law, which requires that a member's registration to

be kept current by supplementary amendments.

    NYSE Arca Equities Rules 9.1(f) and 9.10, which concern sharing in

customer accounts and assumption of customer losses, would be deleted

and the text of FINRA Rule 2150 would be adopted as new NYSE Arca

Equities Rule 2150.

    NYSE Arca Equities Rule 9.15, which concerns customer account

statements, would be deleted and the text of NASD Rule 2340(a) and (b)

and the relevant definitions from paragraph (d) of that Rule would be

adopted as new NYSE Arca Equities Rule 9.15.

    NYSE Arca Equities Rules 9.21(a) through 9.25, which concern

advertising and sales literature, would be deleted and the text of NASD

Rule 2210 would be adopted as new NYSE Arca Equities Rule 9.21.

    The Exchange would also adopt FINRA Rule 2010, which concerns

standards of commercial honor and just and equitable principles of

trade, and FINRA Rule 2020, which concerns the use of manipulative,

deceptive, or other fraudulent devices, as NYSE Arca Equities Rules

2010 and 2020, respectively.

    Finally, the Exchange proposes certain non-substantive technical

changes. For consistency with Exchange rules, the Exchange proposes to

change all references from ``members'' to ``ETP Holders'' and from

``Pacific Exchange'' to ``NYSE Arca'' and to cross-reference to its own

rules where appropriate, rather than NASD or FINRA rules.\11\ Finally,

the Exchange has determined to include references to security futures,

direct participation programs, and collateralized mortgage obligations

in proposed NYSE Arca Equities Rule 9.21, which concerns advertising

and sales literature; although the Exchange currently does not trade

such products, it has determined to maintain such references for the

sake of consistency with FINRA rules.

---------------------------------------------------------------------------

    \11\ For example, in proposed NYSE Arca Equities Rule 6.16(a),

the Exchange proposes to cross-reference proposed NYSE Arca Equities

Rule 2010, rather than FINRA Rule 2010, and in proposed NYSE Arca

Equities Rule 6.16A(d), the Exchange proposes to cross-reference its

definition of ``institutional account'' in NYSE Arca Equities Rule

9.2(a)(3), which is substantially the same as FINRA's definition.

---------------------------------------------------------------------------

2. Statutory Basis

    The proposed rule change is consistent with the Act,\12\ in

general, and furthers the objectives of Section 6(b)(5) of the Act,\13\

in particular, in that it is designed to prevent fraudulent and

manipulative acts and practices, to promote just and equitable

principles of trade, to foster cooperation and coordination with

persons engaged in facilitating transactions in securities, and to

remove impediments to and perfect the mechanism of a free and open

market and a national market system.

---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78f(b).

    \13\ 15 U.S.C. 78f(b)(5).

---------------------------------------------------------------------------

    The Exchange believes that the proposed rule change supports the

objectives of the Act by providing greater harmonization between NYSE

Arca Equities Rules and FINRA Rules of similar purpose, resulting in

less burdensome and more efficient regulatory compliance for dual

members of both SROs. To the extent the Exchange has proposed changes

that differ from the FINRA version of the rules, such changes are

technical in nature and do not change the substance of the proposed

NYSE Arca Equities rules.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will

impose any burden on competition that is not necessary or appropriate

in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed

Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the

proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for

Commission Action

    Because the foregoing proposed rule change does not: (i)

Significantly affect the protection of investors or the public

interest; (ii) impose any significant burden on competition; and (iii)

become operative for 30 days after the date of the filing, or such

shorter time as the Commission may designate, if consistent with the

protection of investors and the public interest, it has become

effective pursuant to Section 19(b)(3)(A) of the Act \14\ and Rule 19b-

4(f)(6) thereunder.\15\

---------------------------------------------------------------------------

    \14\ 15 U.S.C. 78s(b)(3)(A).

    \15\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)

requires a self-regulatory organization to give the Commission

written notice of its intent to file the proposed rule change, along

with a brief description and text of the proposed rule change, at

least five business days prior to the date of filing of the proposed

rule change, or such shorter time as designated by the Commission.

The Exchange has satisfied this requirement.

---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) \16\ normally

does not become operative prior to 30 days after the date of the

filing. However, pursuant to Rule 19b-4(f)(6)(iii),\17\ the Commission

may designate a shorter time if such action is consistent with the

protection of investors and the public interest. The Exchange has asked

the Commission to waive the 30-day operative delay so that the proposal

may become operative immediately upon filing in order to avoid

regulatory gaps between the FINRA and NYSE Arca Equities rules.

---------------------------------------------------------------------------

    \16\ 17 CFR 240.19b-4(f)(6).

    \17\ 17 CFR 240.19b-4(f)(6)(iii).

---------------------------------------------------------------------------

    The Commission believes that waiver of the operative delay would

enable the Exchange to harmonize its rules with FINRA's rules without

delay to support the objectives of the Rule 17d-2 Plan, which provides

that the Common Rules of NYSE Arca Equities and FINRA are to be

substantially similar. The Commission designates the proposal operative

upon filing.\18\

---------------------------------------------------------------------------

    \18\ For purposes only of waiving the operative delay for this

proposal, the Commission has considered the proposed rule's impact

on efficiency, competition, and capital formation. See 15 U.S.C.

78c(f).

---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule

change, the Commission summarily may temporarily suspend such rule

change if it appears to the Commission that such action is necessary or

appropriate in the public interest, for the protection of investors, or

otherwise in furtherance of the purposes of the Act. If the Commission

takes such action, the Commission shall institute proceedings to

determine whether the proposed rule should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and

arguments concerning the foregoing, including whether the proposed rule

change is consistent with the Act. Comments may be submitted by any of

the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or

     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-NYSEArca-2011-40 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,

Secretary, Securities and Exchange Commission, 100 F Street, NE.,

Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2011-40. This

file number should be included on the subject line if e-mail is used.

To help the Commission process and review your comments more

efficiently, please use only one method. The Commission will post all

comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that

are filed with the Commission, and all written communications relating

to the proposed rule change between the Commission and any person,

other than those that may be withheld from the public in accordance

with the provisions of 5 U.S.C. 552, will be available for Web site

viewing and printing in the Commission's Public Reference Room, 100 F

Street, NE.,

Washington, DC 20549, on official business days between the hours of 10

a.m. and 3 p.m. Copies of such filing also will be available for

inspection and copying at the principal office of the Exchange. All

comments received will be posted without change; the Commission does

not edit personal identifying information from submissions. You should

submit only information that you wish to make available publicly. All

submissions should refer to File Number SR-NYSEArca-2011-40 and should

be submitted on or before July 28, 2011.

---------------------------------------------------------------------------

    \19\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Trading and Markets,

pursuant to delegated authority.\19\

Cathy H. Ahn,

Deputy Secretary.

[FR Doc. 2011-16963 Filed 7-6-11; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 86, Number 217 (Monday, November 15, 2021)]
[Notices]
[Pages 63009-63010]
[FR Doc No: 2021-24854]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following exempt
wholesale generator filings:
    Docket Numbers: EG22-22-000.
    Applicants: Skipjack IA, LLC.

    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Skipjack IA, LLC.
    Filed Date: 11/8/21.
    Accession Number: 20211108-5078.
    Comment Date: 5 p.m. ET 11/29/21.

    Take notice that the Commission received the following electric
rate filings:
    Docket Numbers: ER21-2449-002.
    Applicants: Assembly Solar II, LLC.
    Description: Compliance filing: Informational Filing for Achieving
Commercial Operation to be effective 11/5/2021.
    Filed Date: 11/8/21.
    Accession Number: 20211108-5193.
    Comment Date: 5 p.m. ET 11/29/21.

    Docket Numbers: ER22-188-000.
    Applicants: Indra Power Business CT, LLC.
    Description: Supplement to October 22, 2021 Indra Power Business
CT, LLC tariff filing.
    Filed Date: 11/5/21.
    Accession Number: 20211105-5215.
    Comment Date: 5 p.m. ET 11/26/21.

    Docket Numbers: ER22-357-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to WMPA, SA No.
5545; Queue No. AE2-125 to be effective 12/11/2019.
    Filed Date: 11/8/21.
    Accession Number: 20211108-5097.
    Comment Date: 5 p.m. ET 11/29/21.

    Docket Numbers: ER22-358-000.
    Applicants: Public Service Electric and Gas Company, PJM
Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Public Service Electric and
Gas Company submits tariff filing per 35.13(a)(2)(iii: Revisions to the
CTOA, Section 8 re: TO Voting Structure to be effective 1/10/2022.
    Filed Date: 11/8/21.
    Accession Number: 20211108-5109.
    Comment Date: 5 p.m. ET 11/29/21.

    Docket Numbers: ER22-360-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Amendment: Notice of Cancellation of WMPA, SA
No. 4601; Queue Nos. AB2-010/AB2-011 to be effective 2/5/2019.
    Filed Date: 11/8/21.
    Accession Number: 20211108-5139.
    Comment Date: 5 p.m. ET 11/29/21.

    Docket Numbers: ER22-361-000.
    Applicants: AEP Texas Inc.
    Description: Sec.  205(d) Rate Filing: AEPTX-Concho Valley Solar
1st A&R Generation Interconnection Agreement to be effective 10/27/
2021.
    Filed Date: 11/8/21.
    Accession Number: 20211108-5153.
    Comment Date: 5 p.m. ET 11/29/21.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: November 8, 2021.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2021-24854 Filed 11-12-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Rules and Regulations]
[Page 32185]
[FR Doc No: 2021-12749]

========================================================================
Rules and Regulations
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains regulatory documents
having general applicability and legal effect, most of which are keyed
to and codified in the Code of Federal Regulations, which is published
under 50 titles pursuant to 44 U.S.C. 1510.

The Code of Federal Regulations is sold by the Superintendent of Documents.

========================================================================

Federal Register / Vol. 86, No. 115 / Thursday, June 17, 2021 / Rules
and Regulations

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 111

[Docket No.: FAA-2020-0246; Amdt. Nos. 11-65, 91-363, and 111-1A]
RIN 2120-AK31

Pilot Records Database; Correction

AGENCY: Federal Aviation Administration (FAA), U.S. Department of
Transportation (DOT).

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: On June 10, 2021, the FAA published a final rule regarding the
use of an electronic Pilot Records Database (PRD) and implementing
statutory requirements to facilitate the sharing of pilot records among
air carriers and other operators in an electronic data system managed
by the FAA. An error in one of the amendatory instructions resulted in
an incorrect effective date. This document corrects that effective
date.

DATES: This correction is effective August 9, 2021.

FOR FURTHER INFORMATION CONTACT: Christopher Morris, 3500 S MacArthur
Blvd, ARB301, Oklahoma City, Oklahoma 73179; telephone<PHONE_NUMBER>;
email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The final rule, published June 10, 2021, at
86 FR 31006, amends Title 14 of the Code of Federal Regulations (14
CFR) by adding new part 111, Pilot Records Database (PRD). The
amendment adding part 111 was intended to be effective on August 9,
2021, but was erroneously printed with an effective date of September
8, 2021.
    Therefore, in FR Doc. 2021-11424 appearing on page 31006 in the
Federal Register of Thursday, June 10, 2021, the following corrections
are made:

PART 111 [CORRECTED]

0
1. On page 31060, in the second column, in amendment 5, the instruction
``Effective September 8, 2021, add part 111 to subchapter G to read as
follows:'' is corrected to read ``Effective August 9, 2021, add part
111 to subchapter G to read as follows:''
    Issued in Washington, DC, under the authority of 49 U.S.C. 106(f),
U.S.C. 106(f), 106(g) 44701(a), 44703, 44711, 46105, and 46301 on or
about June 11, 2021.

Timothy R. Adams,
Acting Executive Director, Office of Rulemaking, Federal Aviation
Administration.
[FR Doc. 2021-12749 Filed 6-16-21; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 86, Number 48 (Monday, March 15, 2021)]
[Rules and Regulations]
[Pages 14237-14238]
[FR Doc No: 2021-05294]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 25

[Docket No. FAA-2020-1206; Special Conditions No. 25-781-SC]

Special Conditions: Rockwell Collins, Bombardier Model BD-100-
1A10 Airplane; Electronic-System Security Protection From Unauthorized
External Access

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final special conditions; request for comments.

-----------------------------------------------------------------------

SUMMARY: These special conditions are issued for the Bombardier Model
BD-100-1A10 airplane. This airplane, as modified by Rockwell Collins,
will have a novel or unusual design feature when compared to the state
of technology envisioned in the airworthiness standards for transport
category airplanes. This design feature is the installation of a system
that allows connection to airplane electronic systems and networks, and
access from aircraft external to the previously isolated internal
airplane electronic assets. The applicable airworthiness regulations do
not contain adequate or appropriate safety standards for this design
feature. These special conditions contain the additional safety
standards that the Administrator considers necessary to establish a
level of safety equivalent to that established by the existing
airworthiness standards.

DATES: This action is effective on Rockwell Collins on March 15, 2021.
Send comments on or before April 29, 2021.

ADDRESSES: Send comments identified by Docket No. FAA-2020-1206 using
any of the following methods:
     Federal eRegulations Portal: Go to http://www.regulations.gov/ and follow the online instructions for sending
your comments electronically.
     Mail: Send comments to Docket Operations, M-30, U.S.
Department of Transportation (DOT), 1200 New Jersey Avenue SE, Room
W12-140, West Building Ground Floor, Washington, DC 20590-0001.
     Hand Delivery or Courier: Take comments to Docket
Operations in Room W12-140 of the West Building Ground Floor at 1200
New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
     Fax: Fax comments to Docket Operations at<PHONE_NUMBER>.
    Privacy: Except for Confidential Business Information (CBI) as
described in the following paragraph, and other information as
described in 14 CFR 11.35, the FAA will post all comments received
without change, to http://www.regulations.gov/, including any personal
information you provide. The FAA will also post a report summarizing
each substantive verbal contact received about this proposal.
    Confidential Business Information: Confidential Business
Information (CBI) is commercial or financial information that is both
customarily and actually treated as private by its owner. Under the
Freedom of Information Act (FOIA) (5 U.S.C. 552), CBI is exempt from
public disclosure. If your comments responsive to this Notice contain
commercial or financial information that is customarily treated as
private, that you actually treat as private, and that is relevant or
responsive to this Notice, it is important that you clearly designate
the submitted comments as CBI. Please mark each page of your submission
containing CBI as ``PROPIN.'' The FAA will treat such marked
submissions as confidential under the FOIA, and the indicated comments
will not be placed in the public docket of this Notice. Send
submissions containing CBI to the person indicated in the Contact
section below. Comments the FAA receives, which are not specifically
designated as CBI, will be placed in the public docket for this
rulemaking.
    Docket: Background documents or comments received may be read at
http://www.regulations.gov/ at any time. Follow the online instructions
for accessing the docket or go to Docket Operations in Room W12-140 of
the West Building Ground Floor at 1200 New Jersey Avenue SE,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.

FOR FURTHER INFORMATION CONTACT: Varun Khanna, Aircraft Information
Systems Section, AIR-622, Technical Innovation Policy Branch, Policy
and Innovation Division, Aircraft Certification Service, Federal
Aviation Administration, 2200 South 216th Street, Des Moines,
Washington 98198; telephone and fax<PHONE_NUMBER>; email
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The substance of these special conditions
has been published in the Federal Register for public comment in
several prior instances with no substantive comments received.
Therefore, the FAA finds, pursuant to 14 CFR 11.38(b), that new
comments are unlikely, and notice and comment prior to this publication
are unnecessary.

Comments Invited

    The FAA invites interested people to take part in this rulemaking
by sending written comments, data, or views. The most helpful comments
reference a specific portion of the special conditions, explain the
reason for any recommended change, and include supporting data.
    The FAA will consider all comments received by the closing date for
comments. The FAA may change these special conditions based on the
comments received.

Background

    On May 3, 2019, Rockwell Collins applied for a supplemental type
certificate for installation of the Rockwell Collins Pro Line Fusion
System in the Bombardier Model BD-100-1A10 airplane, requiring security
protection from unauthorized external access. The Bombardier Model BD-
100-1A10 airplane is a twin-engine, transport-category airplane with a
passenger capacity of 19 and a maximum takeoff weight of 40,600 pounds.

Type Certification Basis

    Under the provisions of title 14, Code of Federal Regulations (14
CFR) 21.101, Rockwell Collins must show that the Bombardier Model BD-
100-1A10

airplane, as changed, continues to meet the applicable provisions of
the regulations listed in Type Certificate No. T00005NY, or the
applicable regulations in effect on the date of application for the
change, except for earlier amendments as agreed upon by the FAA.
    If the Administrator finds that the applicable airworthiness
regulations (e.g., 14 CFR part 25) do not contain adequate or
appropriate safety standards for the Bombardier Model BD-100-1A10
airplane because of a novel or unusual design feature, special
conditions are prescribed under the provisions of Sec.  21.16.
    Special conditions are initially applicable to the model for which
they are issued. Should the applicant apply for a supplemental type
certificate to modify any other model included on the same type
certificate to incorporate the same novel or unusual design feature,
these special conditions would also apply to the other model under
Sec.  21.101.
    In addition to the applicable airworthiness regulations and special
conditions, the Bombardier Model BD-100-1A10 airplane must comply with
the fuel-vent and exhaust-emission requirements of 14 CFR part 34, and
the noise-certification requirements of 14 CFR part 36.
    The FAA issues special conditions, as defined in 14 CFR 11.19, in
accordance with Sec.  11.38, and they become part of the type
certification basis under Sec.  21.101.

Novel or Unusual Design Features

    The Bombardier Model BD-100-1A10 airplane, as modified by Rockwell
Collins, will incorporate the following novel or unusual design
feature:
    Installation of the Rockwell Collins Pro Line Fusion System, which
allows connection to airplane electronic systems and networks, and
access from aircraft external sources (e.g., operator networks,
wireless devices, internet connectivity, service provider satellite
communications, electronic flight bags, etc.) to the previously
isolated airplane electronic assets.

Discussion

    The Bombardier Model BD-100-1A10 airplane architecture and network
configuration is novel or unusual for commercial transport airplanes
because it may allow increased connectivity to and access from external
network sources and airline operations and maintenance networks to the
airplane control domain and airline information services domain. The
airplane control domain and airline information-services domain perform
functions required for the safe operation and maintenance of the
airplane. Previously, these domains had very limited connectivity with
external network sources. This data network and design integration
creates a potential for unauthorized persons to access the aircraft-
control domain and airline information-services domain, and presents
security vulnerabilities related to the introduction of computer
viruses and worms, user errors, and intentional sabotage of airplane
electronic assets (networks, systems, and databases) critical to the
safety and maintenance of the airplane.
    The existing FAA regulations did not anticipate these networked
airplane system architectures. Furthermore, these regulations and the
current guidance material do not address potential security
vulnerabilities, which could be exploited by unauthorized access to
airplane networks, data buses, and servers. Therefore, these special
conditions ensure that the security (i.e., confidentiality, integrity,
and availability) of airplane systems is not compromised by
unauthorized wired or wireless electronic connections. This includes
ensuring that the security of the airplane's systems is not compromised
during maintenance of the airplane's electronic systems. These special
conditions also require the applicant to provide appropriate
instructions to the operator to maintain all electronic-system
safeguards that have been implemented as part of the original network
design so that this feature does not allow or reintroduce security
threats.
    These special conditions contain the additional safety standards
that the Administrator considers necessary to establish a level of
safety equivalent to that established by the existing airworthiness
standards.

Applicability

    As discussed above, these special conditions are applicable to the
Bombardier Model BD-100-1A10 airplane. Should Rockwell Collins apply at
a later date for a supplemental type certificate to modify any other
model included on Type Certificate No. T00005NY to incorporate the same
novel or unusual design feature, these special conditions would apply
to that model as well.

Conclusion

    This action affects only a certain novel or unusual design feature
on one model of airplane, as modified by Rockwell Collins. It is not a
rule of general applicability and affects only the applicant.

List of Subjects in 14 CFR Part 25

    Aircraft, Aviation safety, Reporting and recordkeeping
requirements.

Authority Citation

    The authority citation for these special conditions is as follows:

    Authority: 49 U.S.C. 106(f), 106(g), 40113, 44701, 44702, 44704.

The Special Conditions

[squf] Accordingly, pursuant to the authority delegated to me by the
Administrator, the following special conditions are issued as part of
the type certification basis for Bombardier Model BD-100-1A10
airplanes, as modified by Rockwell Collins, for airplane electronic-
system security protection from unauthorized external access.
    1. The applicant must ensure airplane electronic-system security
protection from access by unauthorized sources external to the
airplane, including those possibly caused by maintenance activity.
    2. The applicant must ensure that electronic-system security
threats are identified and assessed, and that effective electronic-
system security-protection strategies are implemented to protect the
airplane from all adverse impacts on safety, functionality, and
continued airworthiness.
    3. The applicant must establish appropriate procedures to allow the
operator to ensure that continued airworthiness of the airplane is
maintained, including all post-type-certification modifications that
may have an impact on the approved electronic-system security
safeguards.

    Issued in Des Moines, Washington, on February 9, 2021.
Suzanne Masterson,
Manager, Transport Airplane Strategic Policy Section, Policy and
Innovation Division, Aircraft Certification Service.
[FR Doc. 2021-05294 Filed 3-12-21; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 82, Number 227 (Tuesday, November 28, 2017)]
[Notices]
[Pages 56233-56234]
[FR Doc No: 2017-25588]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Number: PR17-66-000.

    Applicants: Worsham-Steed Gas Storage, LLC.
    Description: Five Year Updated Market Power Assessment of Worsham-
Steed Gas Storage, LLC.
    Filed Date: 5/9/17.
    Accession Number:<PHONE_NUMBER>46.
    Comments/Protests Due: 5 p.m. ET 12/7/17.

    Docket Numbers: RP18-161-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: Sec.  4(d) Rate Filing: Cap Rel Neg Rate Agmt (EOG
34687 to Tenaska 48776) to be effective 11/16/2017.
    Filed Date: 11/15/17.
    Accession Number: 20171115-5086.
    Comments Due: 5 p.m. ET 11/27/17.

    Docket Numbers: RP18-162-000.
    Applicants: Discovery Gas Transmission LLC.
    Description: Sec.  4(d) Rate Filing: 2018 HMRE Surcharge Filing to
be effective 1/1/2018.
    Filed Date: 11/15/17.
    Accession Number: 20171115-5147.
    Comments Due: 5 p.m. ET 11/27/17.

    Docket Numbers: RP18-163-000.
    Applicants: Texas Eastern Transmission, LP.
    Description: Sec.  4(d) Rate Filing: TETLP Nov2017 Cleanup--Remove
Terminated Negotiated Rates to be effective 12/16/2017.
    Filed Date: 11/16/17.
    Accession Number: 20171116-5021.
    Comments Due: 5 p.m. ET 11/28/17.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified date(s). Protests may be considered,
but intervention is necessary to become a party to the proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: November 16, 2017.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2017-25588 Filed 11-27-17; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: August 20, 2007 (Volume 72, Number 160)]
[Notices]
[Page 46464-46465]
[DOCID:fr20au07-60]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-ORD-2006-1010; FRL-8457-3]

Board of Scientific Counselors, Technology for Sustainability
Subcommittee Meeting--September 2007

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act, Public Law 92-
463, the Environmental Protection Agency, Office of Research and
Development (ORD), gives notice of a meeting of the Board of Scientific
Counselors (BOSC) Technology for Sustainability Subcommittee.

DATES: The meeting (via teleconference call) will be held on Thursday,
September 6, 2007 from 3 p.m. to 5 p.m. All times noted are eastern
time. The meeting may adjourn early if all business is finished.
Requests for the draft agenda or for making oral presentations at the
meeting will be accepted up to 1 business day before the meeting.

ADDRESSES: Participation in the conference call will be by
teleconference only--meeting rooms will not be used. Members of the
public may obtain the call-in number and access code for the call from
Clois Slocum, whose contact information is listed under the FOR FURTHER
INFORMATION CONTACT section of this notice. Submit your comments,
identified by Docket ID No. EPA-HQ-ORD-2006-1010, by one of the
following methods:
     http://www.regulations.gov: Follow the on-line

instructions for submitting comments.
     E-mail: Send comments by electronic mail (e-mail) to:
<EMAIL_ADDRESS>Attention Docket ID No. EPA-HQ-ORD-2006-1010.

     Fax: Fax comments to:<PHONE_NUMBER>, Attention Docket ID
No. EPA-HQ-ORD-2006-1010.
     Mail: Send comments by mail to: Board of Scientific
Counselors, Technology for Sustainability Subcommittee Meetings--
Winter/Spring 2007 Docket, Mailcode: 28221T, 1200 Pennsylvania Ave.,
NW., Washington, DC 20460, Attention Docket ID No. EPA-HQ-ORD-2006-
1010.
     Hand Delivery or Courier. Deliver comments to: EPA Docket
Center (EPA/DC), Room B102, EPA West Building, 1301 Constitution
Avenue, NW.,Washington, DC, Attention Docket ID No. EPA-HQ-ORD-2006-
1010. Note: this is not a mailing address. Such deliveries are only
accepted during the docket's normal hours of operation, and special
arrangements should be made for deliveries of boxed information.
    Instructions: Direct your comments to Docket ID No. EPA-HQ-ORD-
2006-1010. EPA's policy is that all comments received will be included
in the public docket without change and may be made available online at
http://www.regulations.gov, including any personal information provided,

unless the comment includes information claimed to be Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Do not submit information that you consider to
be CBI or otherwise protected through http://www.regulations.gov or e-mail.

The http://www.regulations.gov Web site is an ``anonymous access'' system,

which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through http://www.regulations.gov,

your e-mail address will be automatically captured and included as part
of the comment that is placed in the public docket and made available
on the Internet. If you submit an electronic comment, EPA recommends
that you include your name and other contact information in the body of
your comment and with any disk or CD-ROM you submit. If EPA cannot read
your comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses. For additional
information about EPA's public docket visit the EPA Docket Center
homepage at http://www.epa.gov/epahome/dockets.htm.

    Docket: All documents in the docket are listed in the
http://www.regulations.gov index. Although listed in the index, some

information is not publicly available, e.g., CBI or other information
whose disclosure is restricted by statute. Certain other material, such
as copyrighted material, will be publicly available only in hard copy.
Publicly available docket materials are available either electronically
in http://www.regulations.gov or in hard copy at the Board of Scientific

Counselors, Technology for Sustainability Subcommittee Meetings--
Winter/Spring 2007 Docket, EPA/DC, EPA West, Room B102, 1301
Constitution Ave., NW., Washington, DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number

for the Public Reading Room is<PHONE_NUMBER>, and the telephone number
for the ORD Docket is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: The Designated Federal Officer via
mail at: Clois Slocum, USEPA, 26 W. Martin Luther King Drive,
Cincinnati, OH 45268; via phone/voice mail at:<PHONE_NUMBER>; via fax
at:<PHONE_NUMBER>; or via e-mail at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

General Information

    Any member of the public interested in receiving a draft BOSC
agenda or making a presentation at the meeting may contact Clois
Slocum, the Designated Federal Officer, via any of the contact methods
listed in the FOR FURTHER INFORMATION CONTACT section above. In
general, each individual making an oral presentation will be limited to
a total of three minutes.
    The proposed agenda item for the meeting includes but is not
limited to: discussion of the draft report from the review. The meeting
is open to the public.
    Information on Services for Individuals with Disabilities: For
information on access or services for individuals with disabilities,
please contact Clois Slocum<PHONE_NUMBER> or<EMAIL_ADDRESS>To
request accommodation of a disability, please contact Clois Slocum,
preferably at least 10 days prior to the meeting, to give EPA as much
time as possible to process your request.

    Dated: August 10, 2007.
Mary Ellen Radizikowski,
Acting Director, Office of Science Policy.
[FR Doc. E7-16309 Filed 8-17-07; 8:45 am]

BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 102 (Tuesday, May 30, 2017)]
[Notices]
[Pages 24723-24725]
[FR Doc No: 2017-11008]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0493]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Additional Criteria and Procedures for Classifying
Over-the-Counter Drugs as Generally Recognized as Safe and Effective
and Not Misbranded

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the collection of information associated
with the criteria and procedures for classifying over-the-counter (OTC)
drugs as generally recognized as safe and effective and not misbranded.

DATES: Submit either electronic or written comments on the collection
of information by July 31, 2017. Late, untimely filed comments will not
be considered. Electronic comments must be submitted on or before July
31, 2017. The https://www.regulations.gov electronic filing system will
accept comments until midnight Eastern Time at the end of July 31,
2017. Comments received by mail/hand delivery/courier (for written/
paper submissions) will be considered timely if they are postmarked or
the delivery service acceptance receipt is on or before that date.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2010-N-0493 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Additional Criteria and
Procedures for Classifying Over-the-counter Drugs as Generally
Recognized as Safe and Effective and Not Misbranded.'' Received
comments, those received in a timely manner (see DATES), will be placed
in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North,
10A63, 11601 Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information

is necessary for the proper performance of FDA's functions, including
whether the information will have practical utility; (2) the accuracy
of FDA's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques, when appropriate, and other forms of
information technology.

Additional Criteria and Procedures for Classifying OTC Drugs as
Generally Recognized as Safe and Effective and Not Misbranded--21 CFR
330.14; OMB Control Number 0910-0688--Revision

    FDA regulations at Sec.  330.14 (21 CFR 330.14) establish
additional criteria and procedures for classifying OTC drugs as
generally recognized as safe and effective and not misbranded. These
regulations state that OTC drug products introduced into the U.S.
market after the OTC drug review began and OTC drug products without
any marketing experience in the United States can be evaluated under
the monograph process if the conditions (e.g., active ingredients) meet
certain ``time and extent'' criteria outlined in the regulations. The
regulations allow a time and extent application (TEA) to be submitted
to us by any party for our consideration to include new conditions in
the OTC drug monograph system. TEAs must provide evidence described in
Sec.  330.14(c) demonstrating that the condition is eligible for
inclusion in the monograph system. (Section 330.14(d) specifies the
number of copies and address for submission of a TEA.) If a condition
is found eligible, any interested parties can submit safety and
effectiveness information as explained in Sec.  330.14(f). Safety and
effectiveness data includes the data and information listed in Sec.
330.10(a)(2), a listing of all serious adverse drug experiences that
may have occurred (Sec.  330.14(f)(2)), and an official or proposed
compendial monograph (Sec.  330.14(i)).
    Based on our experience with submissions we have received under
Sec.  330.14, we estimate that we will receive two TEAs and two safety
and effectiveness submissions each year, and that it will take
approximately 1,525 hours to prepare a TEA and 2,350 hours to prepare a
comprehensive safety and effectiveness submission. This information is
reflected in rows 1 and 2 of table 1.
    Recently FDA revised its regulations at 21 CFR part 330 (81 FR
84465, November 23, 2016), thus adding 6 hours to FDA's estimated
annual reporting burden for the information collection. Specifically,
Sec.  330.14(j) clarifies the requirements on content and format
criteria for a safety and effectiveness data submission, and provides
procedures for FDA's review of the submissions and determination of
whether a submission is sufficiently complete to permit a substantive
review. Section 330.14(j)(3) describes the process for cases in which
FDA refuses to file the safety and effectiveness data submission. Under
Sec.  330.14(j)(3), if FDA refuses to file the submission, the Agency
will notify the sponsor in writing, state the reason(s) for the
refusal, and provide the sponsor with 30 days in which to submit a
written request for an informal conference with the Agency about
whether the Agency should file the submission. We estimate that
approximately one respondent will annually submit a request for an
informal conference, and that preparing and submitting each request
will take approximately 1 hour. This is reflected in row 3 of table 1.
    Under Sec.  330.14(j)(4)(iii), the safety and effectiveness data
submission must contain a signed statement that the submission
represents a complete safety and effectiveness data submission and that
the submission includes all the safety and effectiveness data and
information available to the sponsor at the time of the submission,
whether positive or negative. We estimate that approximately two
respondents annually will submit such signed statements, and that
preparing and submitting each signed statement will take approximately
1 hour. This is reflected in row 4 of table 1.
    Under Sec.  330.14(k)(1), FDA, in response to a written request
from a sponsor, may withdraw consideration of a TEA submitted under
Sec.  330.14(c) or a safety and effectiveness data submission submitted
under Sec.  330.14(f). We estimate that approximately one respondent
will annually submit such a request, and that preparing and submitting
the request will take approximately 1 hour. This is reflected in row 5
of table 1.
    Under Sec.  330.14(k)(2), a sponsor may request that FDA not
withdraw consideration of a TEA or safety and effectiveness data
submission. We estimate one respondent will annually submit such a
request, and that preparing and submitting the request will take
approximately 2 hours. This is reflected in row 6 of table 1.
    Accordingly, FDA estimates the burden of this collection of
information as follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
    21 CFR part 330; activity        Number of     responses per   Total annual   Average burden    Total hours
                                    respondents     respondent       responses     per response
----------------------------------------------------------------------------------------------------------------
330.14(c) and (d); Time and                    2               1               2           1,525           3,050
 extent application and
 submission of information......
330.14(f) and (i); Safety and                  2               1               2           2,350           4,700
 effectiveness data.............
330.14(j)(3); sponsor request                  1               1               1               1               1
 for informal conference........
330.14(j)(4); sponsor signed                   2               1               2               1               2
 statement that submission is
 complete.......................
330.14(k)(l); sponsor request                  1               1               1               1               1
 for FDA withdraw of TEA
 consideration..................
330.14(k)(2); sponsor request                  1               1               1               2               2
 for FDA to not deem submission
 withdrawn......................
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............           7,756
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    Dated: May 23, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-11008 Filed 5-26-17; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19164]
[FR Doc No: 2016-07532]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Notice of Technical Conference

------------------------------------------------------------------------
                                                           Docket No.
------------------------------------------------------------------------
Review of Generator Interconnection Agreements and          RM16-12-000.
 Procedures..........................................
American Wind Energy Association.....................       RM15-21-000.
------------------------------------------------------------------------

    Take notice that the Federal Energy Regulatory Commission
(Commission) will convene a staff-led technical conference in the
above-referenced proceedings on Friday, May 13, 2016 from 9:30 a.m. to
4:30 p.m. (EDT). The conference will be held in the Commission Meeting
Room at Commission headquarters, 888 First Street NE., Washington, DC
20426. Commissioners may attend and participate.
    The purpose of this conference is to discuss select issues related
to a petition for rulemaking submitted by the American Wind Energy
Association (Docket No. RM15-21-000). In addition, the conference will
explore other generator interconnection issues, including
interconnection of energy storage.\1\
---------------------------------------------------------------------------

    \1\ The comments filed in Docket No. RM15-21-000 will be
incorporated into Docket No. RM16-12-000.
---------------------------------------------------------------------------

    Discussions at the conference may involve issues raised in
proceedings that are currently pending before the Commission. These
proceedings include, but are not limited to:

    E.ON Climate & Renewables North America LLC, Pioneer Trail Wind
Farm, LLC, Settlers Trail Wind Farm, LLC v. Northern Indiana Public
Service Company, Docket No. EL14-66-002;
    Entergy Arkansas, Inc., Docket No. ER14-671-000;
    Internal MISO Generators v. Midcontinent Independent System
Operator, Inc., Docket No. EL15-99-000;
    Midcontinent Independent System Operator, Inc., Docket No. ER16-
675-000;
    California Independent System Operator Corporation, Docket No.
ER16-693-000;
    ISO New England, Inc., Docket No. ER16-946-000;
    Midcontinent Independent System Operator, Inc., Docket No. ER16-
1120-000; and
    Midcontinent Independent System Operator, Inc., Docket No. ER16-
1211-000.

    Additional information regarding the conference program will be
provided in subsequent supplemental notices of technical conference.
    There is no fee for attendance. In-person attendees should allow
time to pass through building security procedures before the 9:30 a.m.
start time of the technical conference. Pre-registration is encouraged
though not required. Attendees may register in advance at the following
Web page: https://www.ferc.gov/whats-new/registration/05-13-16-form.asp.
    The conference will be transcribed and webcast. Transcripts will be
available immediately for a fee from Ace Reporting<PHONE_NUMBER>). A
link to the webcast of this event will be available in the Commission
Calendar of Events at www.ferc.gov. The Capitol Connection provides
technical support for the webcasts and offers the option of listening
to the conferences via phone-bridge for a fee. For additional
information, visit www.CapitolConnection.org or call<PHONE_NUMBER>.
    Commission conferences are accessible under section 508 of the
Rehabilitation Act of 1973. For accessibility accommodations please
send an email to<EMAIL_ADDRESS>or call toll free 1-866-208-
3372 (voice) or<PHONE_NUMBER> (TTY), or send a fax to<PHONE_NUMBER> with
the required accommodations.
    For more information about this technical conference, please
contact Tony Dobbins at<EMAIL_ADDRESS>or<PHONE_NUMBER>. For
information related to logistics, please contact Sarah McKinley at
<EMAIL_ADDRESS>or<PHONE_NUMBER>.

    Dated: March 29, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-07532 Filed 4-1-16; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: November 1, 2010 (Volume 75, Number 210)]
[Notices]
[Page 67093]
[DOCID:fr01no10-31]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

Joint Meeting of the Anesthetic and Life Support Drugs Advisory
Committee and the Drug Safety and Risk Management Advisory Committee;
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.

    Name of Committees: Anesthetic and Life Support Drugs Advisory
Committee and the Drug Safety and Risk Management Advisory
Committee.
    General Function of the Committees: To provide advice and
recommendations to the Agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on December 2, 2010,
from 8 a.m. to 4:30 p.m.
    Location: The Marriott Inn and Conference Center, University of
Maryland University College, The Ballroom, 3501 University Blvd.
East, Adelphi, MD. The hotel telephone number is<PHONE_NUMBER>.
    Contact Person: Kalyani Bhatt, Center for Drug Evaluation and
Research, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 31, rm. 2417, Silver Spring, MD 20993-0002,<PHONE_NUMBER>, FAX:
301-847-8533, e-mail<EMAIL_ADDRESS>or FDA Advisory
Committee Information Line, 1-800-741-8138<PHONE_NUMBER> in the
Washington, DC area), codes<PHONE_NUMBER> or<PHONE_NUMBER>. Please call
the Information Line for up-to-date information on this meeting. A
notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot
always be published quickly enough to provide timely notice.
Therefore, you should always check the agency's Web site and call
the appropriate advisory committee hot line/phone line to learn
about possible modifications before coming to the meeting.
    Agenda: On December 2, 2010, the committees will begin with a
closed session from 8 a.m. to 9:15 a.m. Following the closed
session, from 9:15 a.m. to 4:30 p.m., the meeting will be open to
the public. The committees will discuss new drug application (NDA)
201655, Oxymorphone HCl Extended-Release Tablets, Endo
Pharmaceuticals, Inc., and its safety for the proposed indication of
relief of moderate to severe pain in patients requiring continuous,
around-the-clock opioid treatment for an extended period of time.
The extended-release characteristics of this formulation are
purportedly less easily defeated than other formulations of
controlled-release oxymorphone.
    FDA intends to make background material available to the public
no later than 2 business days before the meeting. If FDA is unable
to post the background material on its Web site prior to the
meeting, the background material will be made publicly available at
the location of the advisory committee meeting, and the background
material will be posted on FDA's Web site after the meeting.
Background material is available at http://www.fda.gov/
AdvisoryCommittees/Calendar/default.htm. Scroll down to the
appropriate advisory committee link.
    Procedure: On December 2, 2010, from 9:15 a.m. to 4:30 p.m., the
meeting is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending
before the committee. Written submissions may be made to the contact
person on or before November 17, 2010. Oral presentations from the
public will be scheduled between approximately 1 p.m. and 2 p.m.
Those desiring to make formal oral presentations should notify the
contact person and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
November 8, 2010. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person
will notify interested persons regarding their request to speak by
November 9, 2010.
    Closed Presentation of Data: On December 2, 2010, from 8 a.m. to
9:15 a.m., the meeting will be closed to permit discussion and
review of trade secret and/or confidential information (5 U.S.C.
552b(c)(4)). During this session, the committee will discuss
confidential protocol and methodology.
    Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to
electrical outlets.
    FDA welcomes the attendance of the public at its advisory
committee meetings and will make every effort to accommodate persons
with physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Kalyani Bhatt at
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory
committee meetings. Please visit our Web site at http://www.fda.gov/
AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for
procedures on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: October 26, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-27457 Filed 10-29-10; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register: June 28, 2011 (Volume 76, Number 124)]
[Notices]
[Page 37804]
[DOCID:fr28jn11-70]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

 [Docket No. EL11-46-000]

NextEra Energy Resources, LLC, Peetz Logan Interconnect, LLC,
PWEC, LLC; Notice of Petition for Declaratory Order

    Take notice that on June 20, 2011, pursuant to Rule 207 of the
Rules of Practice and Procedure of the Federal Energy Regulatory
Commission (FERC or Commission), NextEra Energy Resources, LLC
(NextEra) and two of its indirect subsidiaries, Peetz Logan
Interconnect, LLC (PLI) and PWEC, LLC (PWEC), collectively filed a
petition for declaratory order to confirm the priority rights of PWEC
to capacity over the radial line constructed by PLI to interconnect
NextEra's new wind-powered generation to the integrated transmission
grid. The radial facilities over which this priority access
confirmation is sought include an approximately 78.2 mile, 230 kV
radial transmission line and related equipment and facilities owned by
PLI (collectively, the PLI Facilities). For the convenience in this
petition, all of NextEra's Logan County, Colorado projects collectively
are hereinafter referred to as the Logan County Wind Projects, which
include Logan Wind Energy, LLC, Peetz Table Wind Energy, LLC, and
Northern Colorado Wind Energy, LLC.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://
www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on July 21, 2011.

    Dated: June 21, 2011.
Kimberly D. Bose,
Secretary.
[FR Doc. 2011-16181 Filed 6-27-11; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 80, Number 11 (Friday, January 16, 2015)]
[Notices]
[Pages 2479-2480]
[FR Doc No: 2015-00609]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[FMCSA Docket No. FMCSA-2014-0308]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA confirms its decision to exempt 52 individuals from its
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM)
from operating commercial motor vehicles (CMVs) in interstate commerce.
The exemptions enable these individuals to operate CMVs in interstate
commerce.

DATES: The exemptions were effective on December 9, 2014. The
exemptions expire on December 9, 2016.

FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, R.N., Chief, Medical
Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA, Room
W64-224, Department of Transportation, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

I. Electronic Access

    You may see all the comments online through the Federal Document
Management System (FDMS) at: http://www.regulations.gov.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

II. Background

    On November 7, 2014, FMCSA published a notice of receipt of Federal
diabetes exemption applications from 52 individuals and requested
comments from the public (79 FR 66451). The public comment period
closed on December 8, 2014, and one comment was received.
    FMCSA has evaluated the eligibility of the 52 applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).

Diabetes Mellitus and Driving Experience of the Applicants

    The Agency established the current requirement for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
    FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777),
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
    These 52 applicants have had ITDM over a range of 1 to 38 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the past 5 years. In each case,
an endocrinologist verified that the driver has

demonstrated a willingness to properly monitor and manage his/her
diabetes mellitus, received education related to diabetes management,
and is on a stable insulin regimen. These drivers report no other
disqualifying conditions, including diabetes-related complications.
Each meets the vision requirement at 49 CFR 391.41(b)(10).
    The qualifications and medical condition of each applicant were
stated and discussed in detail in the November 7, 2014, Federal
Register notice and they will not be repeated in this notice.

III. Discussion of Comments

    FMCSA received one comment in this proceeding. The comment is
discussed below.
    Erik Lane stated that he wanted the exemption process to move
faster as he has been unable to work.

IV. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or greater level of safety than
would be achieved without the exemption. The exemption allows the
applicants to operate CMVs in interstate commerce.
    To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
    Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.

V. Conditions and Requirements

    The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.

VI. Conclusion

    Based upon its evaluation of the 52 exemption applications, FMCSA
exempts the following drivers from the diabetes requirement in 49 CFR
391.41(b)(10), subject to the requirements cited above 949 CFR
391.64(b)):

Travis L. Beck (OH)
Corey C. Bennett (MS)
Richard C. Bennett (MA)
Nicholas J. Borelli (NJ)
Bobby L. Brown (MO)
Elvis P. Butler (TN)
John H. Butler (OH)
Michael E. Calvert (TX)
Keith J. Cole (WI)
Kevin E. Conti (OH)
Marsh L. Daggett (TX)
Daniel D. Eisenbise (OK)
Callie W. Freeman (NC)
Brandy D. Green (OK)
Chad E. Hales (UT)
Dennis L. Hooyman (WI)
Lorenza K. Jefferson (VA)
Edward Johnson (TN)
William O. Johnson, Jr. (IN)
Michael E. Kroll (WI)
Thomas J. LaPointe (MA)
Matthew A. Lind (PA)
Cynthia A. Martindale (UT)
Isolina Matos (NJ)
Rex D. McManaway (IL)
Steven A. Metternick (MI)
Daniel P. Miller (PA)
James K. Ollerich (SD)
Scott B. Olson (ND)
Raymond E. Pawloski (MI)
Rodney D. Pedersen (MN)
Loren A. Pingel (CO)
Douglas S. Pitcher (NY)
John E. Pringle (WA)
Terrence A. Proctor (MD)
Salvador Ramirez, Jr. (IL)
Heber E. Rodriguez (VA)
Ethan T. Roy (OH)
Emily J. Runde (WA)
Jerome E. Schwarz (KS)
Lukas N. Skutnik (NE)
Daniel C. Sliman (OH)
Jeffrey A. Sturgill (OH)
Maurice S. Styles (MN)
Steven M. Theys (WI)
Richard J. Thomas (IN)
Kevin E. Tucker (WV)
Robert Vassallo (NY)
Clifford L. White (KS)
Jason L. Woody (KS)
John A. Yarde (IL)
Wesley B. Yokum (PA)

    In accordance with 49 U.S.C. 31136(e) and 31315 each exemption is
valid for two years unless revoked earlier by FMCSA. The exemption will
be revoked if the following occurs: (1) The person fails to comply with
the terms and conditions of the exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the
exemption is still effective at the end of the 2-year period, the
person may apply to FMCSA for a renewal under procedures in effect at
that time.

    Issued on: January 8, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015-00609 Filed 1-15-15; 8:45 am]
BILLING CODE 4910-EX-P